Mucormycosis in COVID-19 patients

Area of Science:

• Mycology
• Infectious Diseases
• Public Health

Background:

• Mucormycosis, a rare fungal infection known as Black Fungus, has seen a significant increase in incidence following the COVID-19 pandemic, particularly during the second wave in India.
• This rise necessitates greater awareness among both healthcare professionals and the general public regarding this opportunistic infection.

Purpose of the Study:

• To provide a comprehensive overview of mucormycosis, focusing on its pathophysiology, etiology, and clinical outcomes.
• To detail current treatment strategies for mucormycosis, with a specific emphasis on the rhino-orbital-cerebral form.
• To consolidate information from existing literature to enhance understanding and management of this emerging health concern.

Main Methods:

• A systematic literature review was conducted.
• Studies were extracted exclusively from the PubMed database.
• The review focused on articles detailing pathophysiology, etiology, case studies, and treatment of mucormycosis, particularly the rhino-orbital-cerebral type.

Main Results:

• The review synthesizes information on the underlying mechanisms and causes of mucormycosis.
• It presents outcomes from various case studies, highlighting the impact of the infection.
• Current therapeutic approaches for managing mucormycosis are discussed.

Conclusions:

• Increased awareness and understanding of mucormycosis are crucial for effective management and public health response.
• Rhino-orbital-cerebral mucormycosis represents a significant clinical challenge requiring prompt diagnosis and treatment.
• Further research and dissemination of knowledge are vital to combat the rising incidence of this fungal infection.